BerandaMNKD • NASDAQ
add
MannKind Corp
$6,84
Setelah Jam Perdagangan Normal:(0,58%)+0,040
$6,88
Tutup: 22 Nov, 19.16.22 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$6,90
Rentang hari
$6,82 - $7,01
Rentang tahun
$3,17 - $7,62
Kapitalisasi pasar
1,89Â M USD
Volume Rata-Rata
2,53Â jt
Rasio P/E
96,18
Hasil dividen
-
Bursa utama
NASDAQ
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 70,08Â jt | 36,73% |
Biaya operasional | 36,84Â jt | 8,46% |
Laba bersih | 11,55Â jt | 571,12% |
Margin laba bersih | 16,48 | 390,48% |
Penghasilan per saham | 0,04 | 300,00% |
EBITDA | 17,33Â jt | 326,29% |
Tarif pajak efektif | 10,26% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 257,49Â jt | 72,33% |
Total aset | 464,20Â jt | 44,91% |
Total liabilitas | 674,13Â jt | 17,83% |
Total ekuitas | -209,93 jt | — |
Saham yang beredar | 275,78 jt | — |
Harga terhadap nilai buku | -9,08 | — |
Tingkat pengembalian aset | 8,38% | — |
Tingkat pengembalian modal | 30,69% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 11,55Â jt | 571,12% |
Kas dari operasi | 9,33Â jt | 7,70% |
Kas dari investasi | -41,26Â jt | -257,23% |
Kas dari pembiayaan | -2,34Â jt | -727,56% |
Perubahan kas bersih | -34,27Â jt | -981,66% |
Arus kas bebas | 5,19Â jt | 157,08% |
Tentang
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
Didirikan
Feb 1991
Kantor pusat
Situs
Karyawan
413
